Listed on NASDAQ since 2007, Accuray Inc. is a medical device manufacturer headquartered in Sunnyvale, CA. In 2011, Accuray acquired TomoTherapy of Madison, WI, and became a major supplier of radiation oncology equipment worldwide with flagship products CyberKnife® and TomoTherapy® machines.

Accuray was a company with less than 500 employees when awarded the Phase I and Phase II contracts in 2010 in response to the DHS DNDO-SBIR solicitation HSHQDC-090R-00041.

Accuray’s motto as a medical device company is “Offering new hope to cancer patients through innovations that help them live longer, better lives.” We are committed to offering our customers leading-edge solutions so they can expand clinical opportunities and offering the best treatment to each patient.

Our entry to the field of cargo security was a development contract from SAIC to build a special linear accelerator- (linac-) based x-ray system for the DNDO-CAARS program. Based on superb performance of the CAARS linac for SAIC in 2009, we applied and received funding from the DNDO-SBIR program to further develop capabilities for non-intrusive inspection (NII) use. We carry the Accuray motto to conduct our industrial business by focusing on innovation opportunities so that our customers can expand the field of using x-ray radiation in the NII of cargos.

The Accuray team is honored to participate in the national endeavor of homeland security against various terrorist threats. The ultimate measure of success for a SBIR project is that the general direction as envisioned by the sponsoring government agency turns into technological innovations that are commercialized in the market place. Accuray has benefited tremendously from this SBIR project in our competence in linac and associated technologies. This has been proven true in both medical and homeland security applications. Along the way, several patents have been applied and some already issued. We are well positioned to be a major supplier of linac systems in the medical and industrial field.